Lactobacilli-lactoferrin interplay in Chlamydia trachomatis infection.

Area of Science:

• Microbiology
• Immunology
• Women's Health

Background:

• Lactobacilli and lactoferrin are key components of the cervicovaginal microenvironment, offering protection against genital infections.
• An imbalanced genital microenvironment increases susceptibility to Chlamydia trachomatis, a prevalent bacterial sexually transmitted infection.
• Lactoferrin exhibits antimicrobial and anti-inflammatory properties, crucial for host defense.

Purpose of the Study:

• To investigate the impact of Lactobacillus crispatus, Lactobacillus brevis, and bovine lactoferrin on Chlamydia trachomatis infection.
• To explore the interplay between host defense mechanisms and C. trachomatis.
• To assess the modulation of chlamydia-induced inflammation by these factors.

Main Methods:

• Quantification of C. trachomatis infectivity and progeny production in cervical epithelial cells.
• Measurement of interleukin-8 (IL-8) and interleukin-6 (IL-6) synthesis.
• Evaluation of the combined effects of L. brevis and bovine lactoferrin on infection and cytokine levels.

Main Results:

• The combination of Lactobacillus brevis and bovine lactoferrin demonstrated significant inhibition of C. trachomatis adhesion and invasion.
• This combination effectively reduced the production of pro-inflammatory cytokines IL-8 and IL-6.
• L. brevis and bovine lactoferrin showed the greatest efficacy in mitigating early-stage infection and inflammation.

Conclusions:

• The synergistic interaction between L. brevis and bovine lactoferrin plays a crucial role in protecting against C. trachomatis infection.
• This combination reduces chlamydial infection burden and modulates the inflammatory response.
• The findings suggest a potential therapeutic role in decreasing the risk of severe complications associated with C. trachomatis.